In a recent guest column published in the Orlando Sentinel, Sue Peschin, president and CEO of the Alliance for Aging Research, writes that the coronavirus has put on display the consequences of rationing health care.
Peschin points to the Institute for Clinical and Economic Review’s (ICER) use of the quality-adjusted life year (QALY) metric in its drug reviews, calling it a “discriminatory algorithm” that hampers access to important drugs.
“The coronavirus emergency has enabled many of us to see first-hand the consequences of attempting to value one life over another,” she writes. “Not only is it unethical, but little research has been done to see whether rationing strategies would even save lives.”
To read the full write up, click here.